louisiana glp-1 gastrointestinal obstruction lawsuit gi in GLP-1 receptor agonists are increasingly used to treat Patients claim blindness, bowel injuries

By adopting a dual-pathway strategysupporting appetite regulation and fat metabolism while also addressing post-weight-loss skin firmnesswe observed significant improvements in body weight and metabolic health, without rebound weight gain or adverse reactions

Merola,

5 Obesity portfolio goes beyond GLP-1 AstraZeneca is building optionality: AZD6234 (long-acting amylin) Phase 2 readout H1 2026 AZD6234 + AZD9550 (GLP-1/glucagon combo) Phase 2 readout H2 2026 $1.2B upfront to CSPC Pharmaceutical Group for ex-China rights to eight programs, led by SYH2082, a once-monthly GLP-1R/GIPR agonist My takeaway Withholding data is risky but moving into Phase 3 is louder than any slide

Combination therapy was also associated with a lower risk of all-cause mortality (RR 0.50 [95% CI 0.40, 0.63]

In treating diabetes, when constipation is an issue, I already switch between Ozempic, the older GLP-1 medicines Victoza and Trulicity, and the newer Mounjaro